SYMRISE AG/ADR (OTCMKTS:SYIEY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Friday, Zacks.com reports.

According to Zacks, “Symrise AG manufactures, develops and sells fragrances, flavorings, cosmetic base materials and substances for the cosmetics industry. The company’s operating segments consists of Scent & Care and Flavor & Nutrition. Scent and Care segment develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas and also develops specific application processes for such substances. Flavor and Nutrition segment develops, produces and sells flavors which are used by customers in the production of food products and beverages. Its product includes perfume, cosmetics and food manufacturers to pharmaceutical companies and producers of nutritional supplements, pet food and baby food. The company operates primarily in Europe, Africa, the Middle East, North America, the Asia Pacific and Latin America. Symrise AG is headquartered in Holzminden, Germany. “

Separately, ValuEngine downgraded Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st.

OTCMKTS:SYIEY opened at $23.01 on Friday. SYMRISE AG/ADR has a twelve month low of $18.15 and a twelve month high of $25.28. The business’s 50 day moving average price is $24.05.

SYMRISE AG/ADR Company Profile

Symrise AG develops, produces, and supplies fragrances, flavorings, cosmetic active ingredients, raw materials, and functional ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

Featured Article: How to execute a trade ex-dividend strategy?

Get a free copy of the Zacks research report on SYMRISE AG/ADR (SYIEY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for SYMRISE AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SYMRISE AG/ADR and related companies with MarketBeat.com's FREE daily email newsletter.